Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Most published data on the use of stereotactic body radiation therapy (SBRT; CyberKnife radiation therapy) has been based on a total radiation dose of 32 to 38 Gy delivered in a series of four or five sessions — as compared to the delivery of more like 75 to 80 Gy using intensity-modulated radiation (IMRT) and [...]
Filed under: Management, Treatment | Tagged: CyberKnife, dose, escalation, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
In today’s news reports we address: Prediction of freedom from biochemical failure after brachytherapy Prediction of probability of unilateral prostate cancer in men eligible for focal therapy Health-related quality of life 5 years after radiotherapy + androgen deprivation Androgen receptor activity “signatures” in men with CRPC
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: androgen receptor activity, brachytherapy, CRPC, dose, focal therapy, HRQOL, outcome, quality of life, signature, unilateral | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site